Log In
BCIQ
Print this Print this
 

c-Met receptor tyrosine kinase (c-MET) (MET) (HGFR) (c-Met proto-oncogene)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting c-Met receptor tyrosine kinase (c-MET) (MET) (HGFR) (c-Met proto-oncogene)

BCIQ
Print ChartPrint this
Marketed, 2 Registration, 1 Phase III, 1 Phase III, 3 Phase II, 1 Phase II, 1 Phase II, 12 Phase I/II, 5 Phase I, 1 Phase I, 17 Preclinical, 7
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIRegistrationMarketed
Cancer

7

17

5

12

3

1

2

Cardiovascular

-

-

-

1

-

-

-

Hepatic

-

1

-

-

-

-

-

Renal

-

-

-

1

-

-

-

Transplant

-

-

-

-

1

-

-




 Products Targeting c-Met receptor tyrosine kinase (c-MET) (MET) (HGFR) (c-Met proto-oncogene)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

18

$4,300.0M

$195.0M

$1,160.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today